SUPERNUS PHARMACEUTICALS, INC. Annual Nonoperating Income (Expense) in USD from 2010 to 2018

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2018.
  • Supernus Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.1M, a 134% increase year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2018 was -$4.27M, a 496% decline from 2017.
  • Supernus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2017 was $1.08M.
  • Supernus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2016 was -$3.85M, a 38.3% increase from 2015.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2018 -$4.27M -$5.35M -496% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-01
2017 $1.08M +$4.92M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
2016 -$3.85M +$2.39M +38.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$6.23M -$1.22M -24.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$5.02M +$25.3M +83.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$30.4M -$26.2M -638% Jan 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
2012 -$4.12M -$2.4M -140% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 -$1.72M -$2.37M -365% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-21
2010 $649K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.